Other Species / Isoforms
  eIF3-alpha (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S11-p
AAAAAGDsDsWDADA
Upstream
0 35
Treatment
  • nocodazole
eIF3-alpha (human) AAAAAGDsDsWDADA S11-p
eIF3-alpha (mouse) AAAAAGDsDsWDADT S14-p
eIF3-alpha (rat) AAAAAGDsDsWDADT S12-p
S13-p
AAAGDsDsWDADAFs
Upstream
0 31
Treatment
  • nocodazole
eIF3-alpha (human) AAAGDsDsWDADAFs S13-p
eIF3-alpha (mouse) AAAGDsDsWDADTFS S16-p
eIF3-alpha (rat) AAAGDsDsWDADTFS S14-p
S20-p
sWDADAFsVEDPVRk
0 9
eIF3-alpha (human) sWDADAFsVEDPVRk S20-p
eIF3-alpha (mouse) sWDADTFSMEDPVRK S23
eIF3-alpha (rat) sWDADTFSMEDPVRK S21
K27-ub
sVEDPVRkVGGGGtA
0 1
eIF3-alpha (human) sVEDPVRkVGGGGtA K27-ub
eIF3-alpha (mouse) SMEDPVRKVAGGGTA K30
eIF3-alpha (rat) SMEDPVRKVAGGGTA K28
T33-p
RkVGGGGtAGGDrWE
0 1
eIF3-alpha (human) RkVGGGGtAGGDrWE T33-p
eIF3-alpha (mouse) RKVAGGGTAGGDRWE T36
eIF3-alpha (rat) RKVAGGGTAGGDRWE T34
R38-m1
GGtAGGDrWEGEDED
0 1
eIF3-alpha (human) GGtAGGDrWEGEDED R38-m1
eIF3-alpha (mouse) GGTAGGDRWEGEDED R41
eIF3-alpha (rat) GGTAGGDRWEGEDED R39
S72-p
VKPEVKIsEKKKIAE
0 2
eIF3-alpha (human) VKPEVKIsEKKKIAE S72-p
eIF3-alpha (mouse) VKPEVKISEKKKIAE S75
eIF3-alpha (rat) VKPEVKISEKKKIAE S73
T109-p
PEEPKVLtPEEQLAD
Upstream
0 41
Treatment
  • EGF
  • LRRK2-IN-1
  • nocodazole
eIF3-alpha (human) PEEPKVLtPEEQLAD T109-p
eIF3-alpha (mouse) PEESKVLtPEEQLAD T112-p
eIF3-alpha (rat) PEESKVLtPEEQLAD T110-p
K117-ac
PEEQLADkLRLKkLQ
0 3
eIF3-alpha (human) PEEQLADkLRLKkLQ K117-ac
eIF3-alpha (mouse) PEEQLADKLRLKKLQ K120
eIF3-alpha (rat) PEEQLADkLRLKKLQ K118-ac
K117-ub
PEEQLADkLRLKkLQ
0 4
eIF3-alpha (human) PEEQLADkLRLKkLQ K117-ub
eIF3-alpha (mouse) PEEQLADkLRLKKLQ K120-ub
eIF3-alpha (rat) PEEQLADKLRLKKLQ K118
K122-ub
ADkLRLKkLQEEsDL
0 1
eIF3-alpha (human) ADkLRLKkLQEEsDL K122-ub
eIF3-alpha (mouse) ADkLRLKKLQEEsDL K125
eIF3-alpha (rat) ADkLRLKKLQEEsDL K123
S127-p
LKkLQEEsDLELAkE
Upstream
Downstream
1 42
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • translation, induced
Putative in vivo kinases:
  • CK2A1 (human)
Treatment
  • nocodazole
  • silmitasertib
eIF3-alpha (human) LKkLQEEsDLELAkE S127-p
eIF3-alpha (mouse) LKKLQEEsDLELAKE S130-p
eIF3-alpha (rat) LKKLQEEsDLELAKE S128-p
K133-ub
EsDLELAkETFGVNN
0 1
eIF3-alpha (human) EsDLELAkETFGVNN K133-ub
eIF3-alpha (mouse) EsDLELAKETFGVNN K136
eIF3-alpha (rat) EsDLELAKETFGVNN K134
Y143-p
FGVNNAVyGIDAMNP
0 6
eIF3-alpha (human) FGVNNAVyGIDAMNP Y143-p
eIF3-alpha (mouse) FGVNNTVYGIDAMNP Y146
eIF3-alpha (rat) FGVNNTVYGIDAMNP Y144
T157-p
PSSRDDFtEFGkLLK
0 1
eIF3-alpha (human) PSSRDDFtEFGkLLK T157-p
eIF3-alpha (mouse) PSSRDDFTEFGkLLK T160
eIF3-alpha (rat) PSSRDDFTEFGKLLK T158
K161-ub
DDFtEFGkLLKDKIT
0 5
eIF3-alpha (human) DDFtEFGkLLKDKIT K161-ub
eIF3-alpha (mouse) DDFTEFGkLLKDKIT K164-ub
eIF3-alpha (rat) DDFTEFGKLLKDKIT K162
Y175-p
TQYEKSLyYASFLEV
0 2
eIF3-alpha (human) TQYEKSLyYASFLEV Y175-p
eIF3-alpha (mouse) TQYEKSLYYASFLEA Y178
eIF3-alpha (rat) TQYEKSLyYASFLEA Y176-p
K197-ac
SLEIDDLkKITNSLT
0 2
eIF3-alpha (human) SLEIDDLkKITNSLT K197-ac
eIF3-alpha (mouse) SLEIDDLKKITNSLT K200
eIF3-alpha (rat) SLEIDDLKKITNSLT K198
S208-p
NSLTVLCsEKQKQEK
Upstream
0 3
Treatment
  • BI2536
eIF3-alpha (human) NSLTVLCsEKQKQEK S208-p
eIF3-alpha (mouse) NSLTVLCsEKQKQEK S211-p
eIF3-alpha (rat) NSLTVLCSEKQKQEK S209
K220-ac
QEKQSKAkkkkkGVV
0 1
eIF3-alpha (human) QEKQSKAkkkkkGVV K220-ac
eIF3-alpha (mouse) QEKQSKAKKKKKGVV K223
eIF3-alpha (rat) QEKQSKAKKKKKGVV K221
K221-ac
EKQSKAkkkkkGVVP
0 1
eIF3-alpha (human) EKQSKAkkkkkGVVP K221-ac
eIF3-alpha (mouse) EKQSKAKKKKKGVVP K224
eIF3-alpha (rat) EKQSKAKKKKKGVVP K222
K222-ac
KQSKAkkkkkGVVPG
0 1
eIF3-alpha (human) KQSKAkkkkkGVVPG K222-ac
eIF3-alpha (mouse) KQSKAKKKKKGVVPG K225
eIF3-alpha (rat) KQSKAKKKKKGVVPG K223
K223-ac
QSKAkkkkkGVVPGG
0 1
eIF3-alpha (human) QSKAkkkkkGVVPGG K223-ac
eIF3-alpha (mouse) QSKAKKKKKGVVPGG K226
eIF3-alpha (rat) QSKAKKKKKGVVPGG K224
K224-ub
SKAkkkkkGVVPGGG
0 1
eIF3-alpha (human) SKAkkkkkGVVPGGG K224-ub
eIF3-alpha (mouse) SKAKKKKKGVVPGGG K227
eIF3-alpha (rat) SKAKKKKKGVVPGGG K225
K233-ub
VVPGGGLkAtMkDDL
0 1
eIF3-alpha (human) VVPGGGLkAtMkDDL K233-ub
eIF3-alpha (mouse) VVPGGGLKATMKDDL K236
eIF3-alpha (rat) VVPGGGLKATMKDDL K234
K233-m1
VVPGGGLkAtMkDDL
0 1
eIF3-alpha (human) VVPGGGLkAtMkDDL K233-m1
eIF3-alpha (mouse) VVPGGGLKATMKDDL K236
eIF3-alpha (rat) VVPGGGLKATMKDDL K234
T235-p
PGGGLkAtMkDDLAD
0 2
eIF3-alpha (human) PGGGLkAtMkDDLAD T235-p
eIF3-alpha (mouse) PGGGLKATMKDDLAD T238
eIF3-alpha (rat) PGGGLKATMKDDLAD T236
K237-m1
GGLkAtMkDDLADyG
0 1
eIF3-alpha (human) GGLkAtMkDDLADyG K237-m1
eIF3-alpha (mouse) GGLKATMKDDLADyG K240
eIF3-alpha (rat) GGLKATMKDDLADyG K238
Y243-p
MkDDLADyGGyDGGy
0 57
eIF3-alpha (human) MkDDLADyGGyDGGy Y243-p
eIF3-alpha (mouse) MKDDLADyGGYEGGY Y246-p
eIF3-alpha (rat) MKDDLADyGGYDGGy Y244-p
Y246-p
DLADyGGyDGGyVQD
0 62
eIF3-alpha (human) DLADyGGyDGGyVQD Y246-p
eIF3-alpha (mouse) DLADyGGYEGGYVQD Y249
eIF3-alpha (rat) DLADyGGYDGGyVQD Y247
Y250-p
yGGyDGGyVQDyEDF
0 61
eIF3-alpha (human) yGGyDGGyVQDyEDF Y250-p
eIF3-alpha (mouse) yGGYEGGYVQDYEDF Y253
eIF3-alpha (rat) yGGYDGGyVQDyEDF Y251-p
Y254-p
DGGyVQDyEDFM___
0 258
eIF3-alpha (human) DGGyVQDyEDFM___ Y254-p
eIF3-alpha (mouse) EGGYVQDYEDFM___ Y257
eIF3-alpha (rat) DGGyVQDyEDFM___ Y255-p